Alnylam Announces New Advances in ATTR Amyloidosis Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Wall St futures rise as yields, oil dip
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 219.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $219.89 | 52 Week High | $109.10 | |||
| Open | $219.89 | 52 Week Low | $31.38 | |||
| Day High | $219.89 | P/E | N/A | |||
| Day Low | $219.89 | EPS | $-1.45 | |||
| Volume | 524 | |||||
